Cycclone Stock Price, News & Analysis

CDBT OTC

Company Description

China Dasheng Biotechnology Co (CDBT) is a company engaged in the development and commercialization of new geometric configuration low carbon emission engines and other clean technology solutions. Recently, CDBT has terminated a consulting agreement with Kenneth Maciora, Empire Relations Group Inc., and Empire Holdings LLC due to failure to deliver work product. With a focus on reducing greenhouse emissions and improving efficiency, CDBT aims to create technologies that make a positive impact on the environment. The company has acquired Cycclone Magnetic Engines, Inc., a pioneering company in the clean technology industry with interests in transport operations in Australia.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$1.2M

Market Cap

41.0M

Shares outstanding

Latest News

View All

No recent news available for Cycclone.

SEC Filings

View All

No SEC filings available for Cycclone.

Financial Highlights

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Loading short interest data...

Days to Cover History

Last 12 Months

Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Cycclone (CDBT)?

The current stock price of Cycclone (CDBT) is $0.048 as of May 19, 2025.

What is the market cap of Cycclone (CDBT)?

The market cap of Cycclone (CDBT) is approximately 1.2M. Learn more about what market capitalization means .

What is China Dasheng Biotechnology Co (CDBT) engaged in?

CDBT is focused on the development and commercialization of low carbon emission engines and clean technology solutions.

Why did CDBT terminate the consulting agreement with Kenneth Maciora?

The termination was due to Maciora's failure to deliver work product as agreed.

What did CDBT acquire recently?

CDBT acquired Cycclone Magnetic Engines, Inc., a company with interests in transport operations in Australia.

What is the main goal of CDBT's technology development?

CDBT aims to reduce greenhouse emissions and improve efficiency with its innovative technologies.

Who is the CEO of CDBT?

The CEO of CDBT is Micheal Nugent.

What are the contact details for CDBT?

For more information, contact CDBT at mnugent@nugent.com.au or visit the website www.cdbtcycclone.com.

What is the focus of Cycclone Magnetic Engines, Inc.?

Cycclone is focused on developing and commercializing low carbon emission engines and clean technology solutions.

What are the key assets of Cycclone Magnetic Engines, Inc.?

Cycclone has shareholding, assets, and interests in transport operations in Australia.

What are the risk factors mentioned in the Safe Harbor Statement?

The risk factors include general business conditions, managing growth, and political and other business risks.

Where can I find more information about CDBT news and developments?

Stay updated with the latest news on China Dasheng Biotechnology Co (CDBT) to learn about the company's latest achievements and projects.